Alexander G Balogh
Overview
Explore the profile of Alexander G Balogh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sartor O, Karrison T, Sandler H, Gomella L, Amin M, Purdy J, et al.
Eur Urol
. 2024 Jun;
86(3):289-290.
PMID: 38897867
Background: Intensification of therapy may improve outcomes for patients with high-risk localized prostate cancer. Objective: To provide long-term follow-up data from phase III RTOG 0521, which compared a combination of...
2.
Sartor O, Karrison T, Sandler H, Gomella L, Amin M, Purdy J, et al.
Eur Urol
. 2023 May;
84(2):156-163.
PMID: 37179241
Background: Intensification of therapy may improve outcomes for patients with high-risk localized prostate cancer. Objective: To provide long-term follow-up data from phase III RTOG 0521, which compared a combination of...
3.
Jackson W, Tang M, Schipper M, Sandler H, Zumsteg Z, Efstathiou J, et al.
J Clin Oncol
. 2022 Jun;
40(27):3172-3179.
PMID: 35737923
Purpose: Metastasis-free survival (MFS), but not event-free survival, is a validated surrogate end point for overall survival (OS) in men treated for localized prostate cancer. It remains unknown if this...
4.
Pollack A, Karrison T, Balogh A, Gomella L, Low D, Bruner D, et al.
Lancet
. 2022 May;
399(10338):1886-1901.
PMID: 35569466
Background: In men with a detectable prostate-specific antigen (PSA) level after prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of patients being free of progression...
5.
Rosenthal S, Hu C, Sartor O, Gomella L, Amin M, Purdy J, et al.
J Clin Oncol
. 2019 Mar;
37(14):1159-1168.
PMID: 30860948
Purpose: Radiotherapy (RT) plus long-term androgen suppression (AS) are a standard treatment option for patients with high-risk localized prostate cancer. We hypothesized that docetaxel chemotherapy (CT) could improve overall survival...
6.
Nichols R, Hu C, Bahary J, Zeitzer K, Souhami L, Leibenhaut M, et al.
Adv Radiat Oncol
. 2017 Dec;
2(4):608-614.
PMID: 29204528
Objectives: We reviewed testosterone changes for patients who were treated with radiation therapy (RT) alone on NRG oncology RTOG 9408. Methods And Materials: Patients (T1b-T2b, prostate-specific antigen <20 ng/mL) were...
7.
Shipley W, Seiferheld W, Lukka H, Major P, Heney N, Grignon D, et al.
N Engl J Med
. 2017 Feb;
376(5):417-428.
PMID: 28146658
Background: Salvage radiation therapy is often necessary in men who have undergone radical prostatectomy and have evidence of prostate-cancer recurrence signaled by a persistently or recurrently elevated prostate-specific antigen (PSA)...
8.
Pisansky T, Hunt D, Gomella L, Amin M, Balogh A, Chinn D, et al.
J Clin Oncol
. 2014 Dec;
33(4):332-9.
PMID: 25534388
Purpose: To determine whether prolonged androgen suppression (AS) duration before radiotherapy improves survival and disease control in prostate cancer. Patients And Methods: One thousand five hundred seventy-nine men with intermediate-risk...